BackNutranomics Overview

Nutranomics EBIT

Latest ebit for NNRX: $-3.2M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.07M
↓ 34.18% YoY

As of Apr 30, 2023

Annual EBIT (TTM)

-$3.23M
↓ 173.66% YoY

Trailing 12 months ending Apr 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Nutranomics (NNRX) FAQ

The latest EBIT for NNRX is $-3.2M as of April 2023. That compares with $-1.2M in the prior-year period — down 173.7% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Nutranomics's historical trend and sector peers before judging valuation or financial health.

Over the past year, NNRX's EBIT moved from $-1.2M to $-3.2M — a 173.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nutranomics's operating scale or balance-sheet position.

Against its sector companies, NNRX currently prints $-3.2M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nutranomics's growth, margins, and balance sheet.

A EBIT figure of $-3.2M for NNRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting NNRX's EBIT ($-3.2M), review year-over-year change from $-1.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.